Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  OTC Bulletin Board - Other OTC  >  Mj Biotech Inc    MJTV

MJ BIOTECH INC

(MJTV)
SummaryQuotesChartsNewsCompany 
News SummaryMost relevantAll newsOfficial PublicationsSector news

MJ Biotech, Inc. Signs Letter of Intent for the Acquisition of a Hemp Based CBD Extraction Laboratory

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/12/2019 | 08:04am EDT

Cheyenne, WY, Feb. 12, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- (OTC: MJTV) MJ Biotech, Inc. (f/k/a Michael James Enterprises, Inc.) has a fully executed Letter of Intent to acquire a California based extraction laboratory producing HEMP based Cannabidiol (CBD) oil.

This acquisition will provide MJ Biotech, Inc. the CBD oil required to produce its CBD infused Teas and Herbs. It will also allow MJ Biotech, Inc. to supply CBD oil to its current wholesale customer base. Once acquired, the Company plans on adding additional equipment to double its current CBD oil production.

CBD is extracted from the flowers and buds of the hemp plants. It does not produce intoxication; marijuana's "high" is caused by the chemical tetrahydrocannabinol (THC). Some of the benefits of CBD: it can reduce pain, relieve depression and anxiety, and promote heart health to name a few.

About MJ Biotech, Inc.

With a mission and commitment to promote health and wellness, MJ BIOTECH, INC., is diligently seeking new Commercial opportunities and relationships.  These exciting new avenues range from the Medical Cannabis sector to healthy lifestyle products. 

It is the MJ BIOTECH, INC., goal to not only promote and provide products for the public good, but to always remember our prime directive is that of enhancing Shareholder value. 

We believe we can achieve both of these objectives by promoting positive lifestyle choices in the Commercial relationships that we create, foster and support. 

For additional information please go to https://mjbiotech.us/

Safe Harbor Statement

This release contains forward-looking statements, which are made pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are commonly identified by words such as "would," "may," "will," "expects," and other terms with similar meaning. Forward-looking statements are based on current beliefs, assumptions and expectations and speak only as of the date of this release and involve risks and uncertainties that could cause actual results to differ materially from current expectations. We assume no obligation to update or revise any forward-looking statement, whether because of new information, future events or any other reason.

For additional information please contact us via email at info@mjbiotech.us


© GlobeNewswire 2019
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on MJ BIOTECH INC
02/12MJ Biotech, Inc. Signs Letter of Intent for the Acquisition of a Hemp Based C..
GL
02/07MJ BIOTECH, INC. : Other Events (form 8-K)
AQ
02/07MJ BIOTECH : Other Events (form 8-K/A)
AQ
2018MJ BIOTECH, INC. : Other Events (form 8-K)
AQ
2018MJ BIOTECH : Management' s discussion and analysis of financial condition and re..
AQ
2018MJ BIOTECH : Management' s discussion and analysis of financial condition and re..
AQ
2018MJ BIOTECH : Management' s discussion and analysis of financial condition and re..
AQ
2018MJ BIOTECH, INC. : Other Events (form 8-K)
AQ
2018MICL JAME : MJ Biotech, Inc. Entered Into Joint Venture Agreement with Drinks 24..
AQ
2018MJ Biotech, Inc. Entered Into Joint Venture Agreement with Drinks 24 Ltd
GL
More news
Chart MJ BIOTECH INC
Duration : Period :
Mj Biotech Inc Technical Analysis Chart | MarketScreener
Full-screen chart
Managers
NameTitle
Maxine C. Pierson CEO, CFO & Principal Accounting Officer
Sector and Competitors
1st jan.Capitalization (M$)
MJ BIOTECH INC-28.75%0
JOHNSON & JOHNSON7.87%371 856
ROCHE HOLDING LTD.8.67%223 303
PFIZER-9.26%219 907
NOVARTIS10.35%204 940
MERCK AND COMPANY-0.09%197 192